Janet L. Smith
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Janet L. Smith has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Andrew P. Sikkema
Epigenetics and RNA Biology Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park , NC 27709
1 shared publication - Ashootosh Tripathi
Natural Products Discovery Core, Life Sciences Institute, University of Michigan, Ann Arbor, USA
1 shared publication - Brian Lee
Life Sciences Institute, University of Michigan, 210 Washtenaw Avenue, Ann Arbor, MI, 48109-2216, USA
1 shared publication - Chuanwu Xi
Department of Environmental Health Sciences, University of Michigan School Of Public Health, Ann Arbor, USA
1 shared publication - David H. Sherman
Life Sciences Institute, University of Michigan, Ann Arbor, MI 48109, USA
1 shared publication - Hyo Je Cho
Department of Pathology, University of Michigan, Ann Arbor, MI, 48109, USA
1 shared publication
Latest Publications
- 21 June 2018
- Published by Wiley in ChemBioChem
- Vol. 19 (15) , 1595-1600
A Defined and Flexible Pocket Explains Aryl Substrate Promiscuity of the Cahuitamycin Starter Unit–Activating Enzyme CahJ
Cahuitamycins are biofilm inhibitors assembled by a convergent nonribosomal peptide synthetase pathway. Previous genetic analysis indicated that a discrete enzyme, CahJ, serves as a gatekeeper for cahuitamycin structural diversification. Here, the CahJ protein was probed structurally and functionally to guide the formation of new analogues by mutasynthetic studies. This analysis enabled the in vivo production of a new cahuitamycin congener through targeted precursor incorporation.
- 21 June 2018
- Published by Wiley in ChemBioChem
- Vol. 19 (15) , 1595-1600
A Defined and Flexible Pocket Explains Aryl Substrate Promiscuity of the Cahuitamycin Starter Unit–Activating Enzyme CahJ
Cahuitamycins are biofilm inhibitors assembled by a convergent nonribosomal peptide synthetase pathway. Previous genetic analysis indicated that a discrete enzyme, CahJ, serves as a gatekeeper for cahuitamycin structural diversification. Here, the CahJ protein was probed structurally and functionally to guide the formation of new analogues by mutasynthetic studies. This analysis enabled the in vivo production of a new cahuitamycin congener through targeted precursor incorporation.